Pharmapedia Pro
Medicines/Generics/Indoramin (HCl)

Indoramin (HCl)

Generic medicine reference

Not yet clinically reviewed

This entry was migrated from the earlier Pharmapedia app bundle and has not been reviewed by a named clinician on this site. It is provided for educational reference only — verify dosage and safety information against current, authoritative sources and a qualified healthcare professional before any clinical use.

Spot an error in this entry? Submit a correction
Overview
Indoramin (HCl) is an alpha-1 selective antagonist of adrenergic receptor. Chemically Indoramin (HCl) is identified as N-[ 1-[2-(1H-indol-3-yl) ethyl ]-4-piperidinyl] benzamide. It produces relaxation of blood vessels and lowers blood pressure. Indoramin (HCl) is used in hypertension and in prophylaxis of migraine. Indoramin (HCl) is prepared by chemical synthesis. Indoramin (HCl) is not available in any combination preparations. Indoramin (HCl) is administered orally.
Indications
Indoramin (HCl) is primarily indicated in conditions like Benign prostatic hyperplasia, Hypertension, Infertility or irregular cycles, Migraine prophylaxis, and can also be given in adjunctive therapy as an alternative drug of choice in Urinary outflow obstruction.
Contraindications
Indoramin (HCl) is contraindicated in conditions like Cardiac failure.
Side Effects
The signs and symptoms that are produced after the acute overdosage of Indoramin (HCl) include Hypotension, Convulsions, Coma, Unconsciousness, Respiratory depression, Hypothermia, Fits. The symptomatic adverse reactions produced by Indoramin (HCl) are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Fatigue, Dry mouth, Sedation, Nasal stiffness, Depression, Weight gain, Failure of ejaculation.
Warnings
Patients should observe caution while driving or performing other tasks requiring alertness, because it may cause drowsiness. Indoramin should be used with caution in patients with hepatic (liver), kidney insufficiency, epilepsy, Parkinson disease or history of depression. It should be avoided in patients with heart failure.
High Risk Groups
Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, patients suffering from Liver Malfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.
Adult Dosage
0.357 to 1.428 mg/kg (0.89 (0.8925)) 12 hourly PO — -
Child Dosage
No child dosage information is recorded for this medicine yet.
Neonatal Dosage
No neonatal dosage information is recorded for this medicine yet.
Drug Interactions
No data regarding the interactions of Indoramin (HCl) was found.
Storage
Tab Store Below 25°C. Protect from Sunlight.

Available Brands in Pakistan

No brands are recorded for this generic.